SBC Medical Group Holdings Incorporated (SBC) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value |
| Current obligations | 78.46M USD | Liabilities, Current |
| Cash and equivalents | 184.31M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | 2.98M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $78.46M | $184.31M | (m) | (m) | $2.98M | (m) |
| 2026-03-31 | (m) | $62.57M | $167.31M | (m) | (m) | $2.32M | (m) |
| 2025-12-31 | (m) | $61.12M | $163.77M | (m) | (m) | $2.79M | (m) |
| 2025-09-30 | (m) | $44.58M | $127.43M | (m) | (m) | $1.68M | (m) |
| 2025-06-30 | (m) | $60.68M | $152.74M | (m) | (m) | $1.71M | (m) |
| 2025-03-31 | (m) | $48.47M | $132.06M | (m) | (m) | $1.69M | (m) |
| 2024-12-31 | (m) | $61.19M | $125.04M | (m) | (m) | $1.49M | (m) |
| 2024-09-30 | (m) | $72.42M | $137.39M | (m) | (m) | $1.99M | (m) |
| 2024-06-30 | (m) | $4.48M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $4.40M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $2.61M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $2.45M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $2.49M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $837.05K | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $566.01K | $485.56K | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $260.46K | $579.97K | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | $179.43K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |